EXPRESSION OF TYPE-III HYPERLIPOPROTEINEMIA IN A SUBJECT WITH SECONDARY HYPOTHYROIDISM BEARING THE APOLIPOPROTEIN E2/2 PHENOTYPE

被引:11
|
作者
FEUSSNER, G
ZIEGLER, R
机构
[1] Department of Internal Medicine I, Endocrinology and Metabolism, University of Heidelberg, Heidelberg
关键词
APOLIPOPROTEIN-E; FAMILIAL DYSBETALIPOPROTEINEMIA; SECONDARY HYPOTHYROIDISM; TYPE-III HYPERLIPOPROTEINEMIA;
D O I
10.1111/j.1365-2796.1991.tb00428.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Post-surgical hypothyroidism developed in a now 43-year-old woman with complete insufficiency of the anterior pituitary gland who discontinued levothyroxine replacement therapy. Serum cholesterol and serum triglyceride levels increased in parallel, and classical type III hyperlipoproteinaemia (HLP) with xanthoma striata palmaris developed. The patient is homozygous for apolipoprotein (apo) E2. The case reported here represents the first example of manifestation of type III hyperlipoproteinaemia in a subject with secondary hypothyroidism bearing the apo E2/2 phenotype.
引用
收藏
页码:183 / 186
页数:4
相关论文
共 50 条
  • [31] Type III hyperlipoproteinema with apolipoprotein E2/2 genotype in Japan
    Eto, M
    Saito, M
    Nakata, H
    Iwashima, Y
    Watanabe, K
    Ikoda, A
    Kaku, K
    CLINICAL GENETICS, 2002, 61 (06) : 416 - 422
  • [32] APOLIPOPROTEIN E-1-HARRISBURG(H) - A POINT MUTATION RESULTING IN DOMINANT EXPRESSION OF TYPE-III HYPERLIPOPROTEINEMIA
    MANN, AW
    GREGG, RE
    RONAN, R
    THOMAS, F
    ZECH, LA
    BREWER, HB
    ARTERIOSCLEROSIS, 1988, 8 (05): : A612 - A612
  • [33] NEW MUTANTS OF APOLIPOPROTEIN-E ASSOCIATED WITH ATHEROSCLEROTIC DISEASES BUT NOT TO TYPE-III HYPERLIPOPROTEINEMIA
    YAMAMURA, T
    YAMAMOTO, A
    SUMIYOSHI, T
    HIRAMORI, K
    NISHIOEDA, Y
    NAMBU, S
    JOURNAL OF CLINICAL INVESTIGATION, 1984, 74 (04): : 1229 - 1237
  • [34] APOLIPOPROTEIN E1 LYS-146-]GLU WITH TYPE-III HYPERLIPOPROTEINEMIA
    MORIYAMA, K
    SASAKI, J
    MATSUNAGA, A
    ARAKAWA, F
    TAKADA, Y
    ARAKI, K
    KANEKO, S
    ARAKAWA, K
    BIOCHIMICA ET BIOPHYSICA ACTA, 1992, 1128 (01) : 58 - 64
  • [35] CHARACTERIZATION OF A UNIQUE HUMAN APOLIPOPROTEIN-E VARIANT ASSOCIATED WITH TYPE-III HYPERLIPOPROTEINEMIA
    ZANNIS, VI
    BRESLOW, JL
    JOURNAL OF BIOLOGICAL CHEMISTRY, 1980, 255 (05) : 1759 - 1762
  • [36] APOLIPOPROTEIN E-1-HARRISBURG - A NEW VARIANT OF APOLIPOPROTEIN-E DOMINANTLY ASSOCIATED WITH TYPE-III HYPERLIPOPROTEINEMIA
    MANN, WA
    GREGG, RE
    SPRECHER, DL
    BREWER, HB
    BIOCHIMICA ET BIOPHYSICA ACTA, 1989, 1005 (03) : 239 - 244
  • [37] TYPE-III HYPERLIPOPROTEINEMIA - ANALYSIS OF 2 CONTEMPORARY DEFINITIONS
    FREDRICKSON, DS
    MORGANROTH, J
    LEVY, RI
    ANNALS OF INTERNAL MEDICINE, 1975, 82 (02) : 150 - 157
  • [38] SEVERE TYPE-III HYPERLIPOPROTEINEMIA ASSOCIATED WITH UNUSUAL APOLIPOPROTEIN-E1 PHENOTYPE AND EPSILON-1 NULL GENOTYPE
    FEUSSNER, G
    FUNKE, H
    WENG, W
    ASSMANN, G
    LACKNER, KJ
    ZIEGLER, R
    EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 1992, 22 (09) : 599 - 608
  • [39] DEFECTIVE RECEPTOR-BINDING OF BETA-VLDL IN TYPE-III HYPERLIPOPROTEINEMIA DUE TO ABNORMAL APOLIPOPROTEIN-E2
    HUI, DY
    INNERARITY, TL
    MAHLEY, RW
    FEDERATION PROCEEDINGS, 1983, 42 (04) : 1061 - 1061
  • [40] HEPARAN-SULFATE PROTEOGLYCAN BINDING OF APOLIPOPROTEIN-E VARIANTS AS A FACTOR MODULATING EXPRESSION OF TYPE-III HYPERLIPOPROTEINEMIA
    JI, ZS
    FAZIO, S
    MAHLEY, RW
    CIRCULATION, 1993, 88 (04) : 365 - 365